Prostate Cancer Foundation's rating was adjusted for Joint Costs. If you are a donor who considers direct mail, telemarketing, and other Joint Cost solicitations to be true charitable programs, the below efficiency ratios, which were not adjusted for joint costs, may better reflect your goals.
| Program % | Cost to Raise $100 |
|---|---|
| 83% | $9 |
| Entity | Document Type | Tax ID |
|---|---|---|
| Prostate Cancer Foundation | Consolidated Audited Financial Statements | Multiple |
| Prostate Cancer Foundation | IRS Form 990 | 95-4418411 |
|
Entity: Prostate Cancer Foundation Document Type: Consolidated Audited Financial Statements Tax ID: Multiple |
|
Entity: Prostate Cancer Foundation Document Type: IRS Form 990 Tax ID: 95-4418411 |
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Charles Ryan | CEO | $792,413 |
| 2 | Howard Soule | EVP / Chief Science Officer | $644,194 |
| 3 | Gina Carithers | EVP / President | $642,880 |
|
1 Name: Charles Ryan Title: CEO Compensation: $792,413 |
|
2 Name: Howard Soule Title: EVP / Chief Science Officer Compensation: $644,194 |
|
3 Name: Gina Carithers Title: EVP / President Compensation: $642,880 |
According to the Prostate Cancer Foundation (PCF) consolidated audit of December 31, 2023 (Note 11, Related Party Transactions): "...Since the foundation's inception in 1993 through December 31, 2023, it has received more than $79 million in contributions from The Michael and Lori Milken Family Foundation, the Milken Family Foundation, and affiliated organizations and individuals." [PCF reports Michael Milken as "Founder & Chairman," and Lori Milken as "Director/VP" (IRS Form 990, Part VII)]. |
According to the Prostate Cancer Foundation (PCF) 2023 tax filing, PCF reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III): Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7): "The [compensation] committee awarded the discretionary bonuses to the officers and employees based on exceptional individual performance." PCF reports "Bonus & incentive compensation" payments to nine individuals in 2023, including $200,000 paid to Gina Carithers, EVP, President, whose reported total compensation in 2023 is $642,880. The reported "Bonus & incentive compensation" amounts for the other eight individuals ranged from $10,000 to $100,000, with associated reported total compensation ranging from $229,742 to $792,413 (IRS Form 990, Schedule J, Part II). |
According to the Prostate Cancer Foundation (PCF) 2023 tax filing, re: the existence of a family or business relationship among officers, directors, trustees, or key employees (IRS Form 990, Part VI, Section A, line 2), the Foundation reported: "Michael Milken (Chairman) family and business relationship; Lori Milken (Director/VP) family and business relationships; Ralph Finerman (Treasurer/CFO) business relationship; Richard Sandler (Director) business relationship" (IRS Form 990, Schedule O). PCF reports Michael Milken as "Founder & Chairman," Lori Milken as "Director/VP," Ralph Finerman as "CFO, Treasurer, Secretary," and Richard Sandler as a "Director." All four individuals are listed as an "Individual Trustee or Director," and Michael Milken, Lori Milken, and Ralph Finerman are also listed as an "Officer" (IRS Form 990, Part VII). PCF reports having 34 voting members on its governing body at the end of 2023, with 32 being independent (IRS Form 990, Part VI, Section A, lines 1a & 1b). |
